Advisorshares Psychedelics Etf Profile

PSIL Etf  USD 12.18  0.27  2.27%   

Performance

5 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 9

 
High
 
Low
Low
AdvisorShares Psychedelics is selling for 12.18 as of the 24th of November 2024. This is a 2.27 percent increase since the beginning of the trading day. The etf's lowest day price was 11.8. AdvisorShares Psychedelics has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for AdvisorShares Psychedelics ETF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of August 2023 and ending today, the 24th of November 2024. Click here to learn more.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. More on AdvisorShares Psychedelics ETF

Moving against AdvisorShares Etf

  0.8ICLN iShares Global CleanPairCorr
  0.71TAN Invesco Solar ETFPairCorr
  0.6GREI Goldman Sachs FuturePairCorr
  0.5ENTR ERShares Entrepreneurs Symbol ChangePairCorr
  0.48QCLN First Trust NASDAQPairCorr
  0.4MJ Amplify ETF TrustPairCorr

AdvisorShares Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationTheme ETFs, Strategy ETFs, Miscellaneous Sector, AdvisorShares (View all Sectors)
IssuerAdvisorShares
Inception Date2021-09-15
Entity TypeRegulated Investment Company
Asset Under Management6.5 Million
Asset TypeEquity
CategoryStrategy
FocusTheme
Market ConcentrationBlended Development
RegionGlobal
AdministratorThe Bank of New York Mellon Corporation
AdvisorAdvisorShares Investments, LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Portfolio ManagerDan S. Ahrens
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End30-Jun
ExchangeNYSE Arca, Inc.
Number of Constituents28.0
Market MakerVirtu Financial
Total Expense3.01
Management Fee0.6
Country NameUSA
Returns Y T D(11.17)
NameAdvisorShares Psychedelics ETF
Currency CodeUSD
Open FigiBBG012JLNFB6
In Threey Volatility56.84
1y Volatility69.12
200 Day M A11.5258
50 Day M A10.4857
CodePSIL
Updated At23rd of November 2024
Currency NameUS Dollar
In Threey Sharp Ratio(0.98)
TypeETF
AdvisorShares Psychedelics ETF [PSIL] is traded in USA and was established 2021-09-15. The fund is listed under Miscellaneous Sector category and is part of AdvisorShares family. The entity is thematically classified as Theme ETFs. AdvisorShares Psychedelics at this time have 7.74 M in assets. , while the total return for the last 3 years was -45.8%.
Check AdvisorShares Psychedelics Probability Of Bankruptcy

Geographic Allocation (%)

AdvisorShares Psychedelics Currency Exposure

AdvisorShares Psychedelics ETF holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of AdvisorShares Psychedelics will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in AdvisorShares Psychedelics ETF.

Top AdvisorShares Psychedelics ETF Etf Constituents

ATAIATAI Life SciencesStockHealth Care
RLMDRelmada TherapeuticsStockHealth Care
GBNHGreenbrook TMSStockHealth Care
MNMDMind MedicineStockHealth Care
ALKSAlkermes PlcStockHealth Care
SAGESage TherapeuticStockHealth Care
GHRSGH Research PLCStockHealth Care
CMPSCompass Pathways PlcStockHealth Care
More Details

AdvisorShares Psychedelics Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AdvisorShares Psychedelics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

AdvisorShares Psychedelics Against Markets

When determining whether AdvisorShares Psychedelics is a strong investment it is important to analyze AdvisorShares Psychedelics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AdvisorShares Psychedelics' future performance. For an informed investment choice regarding AdvisorShares Etf, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in AdvisorShares Psychedelics ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.